Liposomal Bupivacaine for Pain Control After Total Shoulder Arthroplasty
Status:
Completed
Trial end date:
2019-04-15
Target enrollment:
Participant gender:
Summary
This study will compare interscalene nerve block versus liposomal bupivacaine (Exparel) for
pain control after total shoulder replacements. Each method will be assessed in terms of post
operative pain scores, pain medication consumption, length of stay, complications (nerve
injuries, hematomas, cardiac/respiratory events) and rate of readmission due to pain. The
aims of this study will be achieved through a randomized controlled trial and
cost-effectiveness analysis.
Phase:
N/A
Details
Lead Sponsor:
Johns Hopkins University
Collaborators:
Southern Maryland Orthopaedic & Sports Medicine Center University of Texas Southwestern Medical Center William Beaumont Army Medical Center